Schlomo Staszewski

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

Matthias Egger, Margaret May, Geneviève Chêne et al. · The Lancet · 2002 · 1.5K citations

Hiv-1-infected Patients, Treatment And Prevention, Human Retrovirus +9

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

Schlomo Staszewski, Javier O Morales-Ramirez, Karen T. Tashima et al. · New England Journal of Medicine · 1999 · 1K citations · Full text

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1

Gerd Fätkenheuer, Anton Pozniak, Margaret Johnson et al. · Nature Medicine · 2005 · 490 citations

Treatment And Prevention, Medicine, Immunology +10

A Rapid Method for Simultaneous Detection of Phenotypic Resistance to Inhibitors of Protease and Reverse Transcriptase in Recombinant Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Antiretroviral Drugs

Kurt Hertogs, Marie‐Pierre de Béthune, Veronica Miller et al. · Antimicrobial Agents and Chemotherapy · 1998 · 391 citations · Full text

The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial

Joseph J. Eron, Patrick Yéni, Joseph Gathe et al. · The Lancet · 2006 · 341 citations

Klean Study, Treatment And Prevention, Hiv Infection +9